Patents

FILE- In this Jan. 9, 2019, file photo a sign advertises 5G at the Qualcomm booth at CES International in Las Vegas. A federal appeals court on Tuesday, Aug. 11, 2020, has overturned an antitrust ruling against Qualcomm, dismissing arguments that it unlawfully squeezed out cellphone chip rivals and charged excessive royalties to manufacturers such as Apple. The 3-judge panel unanimously sided with the San Diego chipmaker in tossing out a ruling on a lawsuit brought by the U.S. Federal Trade Commission. (AP Photo/John Locher, File)
August 11, 2020 - 9:22 pm
SAN FRANCISCO (AP) — A federal appeals court has overturned an antitrust ruling against Qualcomm, dismissing arguments that it unlawfully squeezed out cellphone chip rivals and charged excessive royalties to manufacturers such as Apple. The 3-judge panel unanimously sided with the San Diego...
Read More
July 23, 2020 - 10:30 am
BERLIN (AP) — A German federal court cleared the way Thursday for Ritter Sport to maintain its status as the only widely known square chocolate in its home market. The Federal Court of Justice delivered its verdict in a back-and-forth, decade-long battle between Ritter and rival Milka, whose owner...
Read More
A lab technician works during research on coronavirus, COVID-19, at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, Wednesday, June 17, 2020. Janssen Pharmaceutical hopes to begin clinical trials on a potential vaccine for COVID-19 in the middle of the summer. (AP Photo/Virginia Mayo)
June 18, 2020 - 7:53 am
LONDON (AP) — As the race intensifies for a vaccine against the new coronavirus, rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunized first — leaving significant questions about whether developing countries will get any...
Read More
China's ambassador in Geneva ambassador Chen Xu makes a media statement criticising the U.S. for attacking China's candidate to head a United Nations agency that tracks intellectual property in the digital age, in Geneva, Switzerland, Wednesday Feb. 26, 2020. The showdown over leadership of the World Intellectual Property Organization that monitors patents, trademarks and industrial design, amounts to the latest face-off between the United States and China. (AP Photo)
February 26, 2020 - 2:45 pm
GENEVA (AP) — A Chinese ambassador on Wednesday ripped into the U.S. for an “attack” on China's candidate to head a United Nations agency that monitors and tracks intellectual property like patents, trademarks and industrial designs — a lucrative and crucial part of the growing digital age. The...
Read More
FILE - This Thursday, March 12, 2009, file photo shows Gilead Sciences Inc. headquarters in Foster City, Calif. Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling more of the conflict over technology policy that helped trigger Washington’s tariff war with Beijing. (AP Photo/Paul Sakuma, File)
February 06, 2020 - 1:47 pm
BEIJING (AP) — Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger Washington’s tariff war with Beijing. The government-run...
Read More
FILE - This Thursday, March 12, 2009, file photo shows Gilead Sciences Inc. headquarters in Foster City, Calif. Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling more of the conflict over technology policy that helped trigger Washington’s tariff war with Beijing. (AP Photo/Paul Sakuma, File)
February 06, 2020 - 11:51 am
BEIJING (AP) — Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger Washington’s tariff war with Beijing. The government-run...
Read More
FILE - In this Jan. 29, 2019, file photo, the logos of Huawei are displayed at its retail shop window reflecting the Ministry of Foreign Affairs office in Beijing. Chinese tech giant Huawei has accused U.S. phone carrier Verizon of violating its patents in a lawsuit, broadening efforts to defend its business in the United States amid government sanctions. (AP Photo/Andy Wong, File)
February 06, 2020 - 11:20 am
BEIJING (AP) — Chinese tech giant Huawei accused U.S. phone company Verizon of violating its patents in a lawsuit Thursday, broadening efforts to defend the company's business in the United States amid government sanctions. Huawei Technologies Ltd. accused Verizon Communications Inc. of violating...
Read More
FILE - In this Jan. 29, 2019, file photo, the logos of Huawei are displayed at its retail shop window reflecting the Ministry of Foreign Affairs office in Beijing. Chinese tech giant Huawei has accused U.S. phone carrier Verizon of violating its patents in a lawsuit, broadening efforts to defend its business in the United States amid government sanctions. (AP Photo/Andy Wong, File)
February 06, 2020 - 5:01 am
BEIJING (AP) — Chinese tech giant Huawei accused U.S. phone carrier Verizon of violating its patents in a lawsuit filed Thursday, broadening efforts to defend company's business in the United States amid government sanctions. Huawei Technologies Ltd. accused Verizon Communications Inc. of violating...
Read More
FILE - This Thursday, March 12, 2009, file photo shows Gilead Sciences Inc. headquarters in Foster City, Calif. Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling more of the conflict over technology policy that helped trigger Washington’s tariff war with Beijing. (AP Photo/Paul Sakuma, File)
February 06, 2020 - 12:39 am
BEIJING (AP) — Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger Washington’s tariff war with Beijing. The government-run...
Read More
FILE - This Thursday, March 12, 2009, file photo shows Gilead Sciences Inc. headquarters in Foster City, Calif. Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling more of the conflict over technology policy that helped trigger Washington’s tariff war with Beijing. (AP Photo/Paul Sakuma, File)
February 06, 2020 - 12:10 am
BEIJING (AP) — Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling more of the conflict over technology policy that helped trigger Washington’s tariff war with Beijing. The...
Read More

Pages